TUMCREATE is a research platform for the improvement of Singapore's public health. Researchers from Technical University Munich and Nanyang Technological University join forces and are funded by Singapore’s National Research Foundation as part of the Campus for Research Excellence and Technological Enterprise (CREATE).
In TUMCREATE, over 100 scientists, researchers and engineers work together, led by Professors from the Technical University of Munich and Nanyang Technological University. More information about TUMCREATE can be found on our web pages at www.tum-create.edu.sg.
Complete blood counts are the most requested clinical in vitro diagnostic tests. Imaging flow cytometry for next-generation hematology analyzer is a promising method for the transfer of preclinical biomarker to the clinic to solve unmet need in diagnosing fever. The candidate is supported within the National Research Foundation (NRF) funded project CellFACE (cooperation between A*Star, NTU, NUH, NUS, Sunningdale Tech Ltd., Technical University of Munich) the development of an imaging flow cytometer for clinical diagnostic studies:
Build a calibration table of biomarkers with life science groups
Develop a quality control routine for imaging to perform clinical studies
Imaging of patient blood samples
Biomarker analysis using machine learning
Managing of clinical sample logistics
PhD degree in Computer Sciences/Biomedical Engineering or related biophysical disciplines
1yr experience in flow cytometry, image analysis, deep learning and python programming
Transdisciplinary research work between engineering, life sciences, and clinical research
Strong communication skills in engineering and life sciences
Working location in Singapore
Dynamic, multicultural and self-defined work environment in the heart of Asia
Attractive income and medical benefits
Working with medical technology prototypes and cooperation with clinical partner
Please send your complete application including cover letter, CV, university transcripts and degree certificates to email@example.com.